CGM patch market seen reaching $13.89 billion by 2030

The real-time blood glucose continuous glucose monitoring patch market is projected to grow from $7.04 billion in 2025 to $8.08 billion in 2026, with demand driven by rising diabetes cases and broader use of wearable medical devices. The Business Research Company says the market could reach $13.89 billion by 2030 as telehealth, homecare diagnostics and real-time analytics expand.

Why it matters: - The CGM patch market is tied directly to diabetes management, a growing global health need. - Real-time monitoring can help patients detect dangerous glucose swings sooner and make faster decisions on diet, medication and lifestyle. - The market's growth signals rising demand for wearable tools that reduce reliance on fingerstick testing.

What happened: - The Business Research Company released its Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Global Market Report 2026 – Market Size and Forecast 2026-2035. - The report values the market at $7.04 billion in 2025 and $8.08 billion in 2026. - The report forecasts the market will reach $13.89 billion by 2030. - The report was published Aug. 26, 2026, from London. - Download a free sample of the report. - View the full market report.

The details: - The market is projected to grow at a 14.8% compound annual growth rate in 2026, after historic growth driven by more diabetes cases, greater awareness of glucose self-monitoring, wider use of wearable medical devices, expanded hospital diabetes care and better sensor precision. - The forecast period calls for a 14.5% CAGR through 2030. - The report links future growth to real-time data analytics, telehealth adoption, personalized diabetes management, homecare diagnostic services and investment in continuous monitoring technologies. - The report points to patch-based glucose monitoring, real-time glucose tracking, non-invasive or minimally invasive methods, home-based diabetes management and early disease detection as major trends. - A real-time blood glucose CGM patch continuously measures glucose in interstitial fluid under the skin. - The device sends readings to a connected display or mobile device and uses a sensor plus transmitter to deliver frequent updates. - The patch reduces the need for traditional fingerstick blood tests. - Diabetes is a chronic metabolic disorder marked by elevated blood sugar from insufficient insulin or insulin resistance. - Rising obesity rates are increasing insulin resistance and lifting the risk of type 2 diabetes. - Real-time CGM patches provide alerts for high and low glucose levels, supporting clinical and day-to-day diabetes decisions. - In June 2024, the UK National Health Service said more than half a million new people in England were at risk of type 2 diabetes in 2023. - The NHS said the total number of people with pre-diabetes registered with a GP in England reached 3,615,330, up nearly 20% from 3,065,825 in 2022. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables.

Between the lines: - The report shows CGM patches moving from niche diabetes tech toward a broader home-care and telehealth toolset. - The strongest demand case appears to be convenience plus earlier warning, not just better measurement. - Fast growth in Asia-Pacific suggests the market opportunity is widening beyond the largest current base in North America.

What's next: - The market's next stage will likely center on better sensor accuracy, more remote monitoring and tighter integration with digital care platforms. - Report buyers can contact Saumya Sahay at marketing@tbrc.info or call the listed regional numbers for sales and expert access. - The Business Research Company directs readers to its website and social channels for more information.

The bottom line: - CGM patches are becoming a major diabetes-care category, and the next few years should bring faster adoption as monitoring moves closer to real time, home-based care and personalized treatment.